Endo, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NDOI
Endo, INC10-Q: Endo Inc. Reports Q1 2025 Results, Impacted by Fresh Start Accounting and Strategic Transactions
Endo Inc.'s Q1 2025 results reflect the impact of fresh start accounting following its bankruptcy emergence, along with strategic moves including a planned merger with Mallinckrodt and the divestiture of its International Pharmaceuticals business.
NDOI
Endo, INCEndo Inc. releases its third quarter 2024 financial results, marking its first reporting period as a reorganized entity following its emergence from Chapter 11 bankruptcy.
NDOI
Endo, INCEndo Inc. released its second quarter 2024 financial results, marking its first reporting period as a reorganized entity after emerging from Chapter 11 bankruptcy.